Navigation Links
Quick microchip test for dangerous antibiotic resistant bacteria
Date:9/4/2007

Researchers at the Veterinary Laboratories Agency in Surrey have developed microchips capable of quickly and cheaply identifying dangerous and drug resistant bacteria in clinical samples, scientists announced today (Wednesday 5 September 2007) at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.

For the first time doctors and veterinarians will be able to test clinical samples from their patients for the presence of the genes for antibiotic resistance in bacteria, getting the results within 24 hours instead of having to wait for as much as a week.

"We have developed a test chip which can accurately identify 56 virulence genes in the diarrhoea-causing Escherichia coli bacteria and 54 antimicrobial resistance genes covering all the known families of gram-negative bacteria", says Dr Muna Anjum from the UKs Veterinary Laboratories Agency in Addlestone, Surrey.

The chip will speed up the process of diagnosis and treatment by giving quicker results from clinical testing laboratories. The chip will also make it possible to carry out routine surveillance studies to monitor the way genes for virulence and antimicrobial resistance are spread in the environment, food samples, or even in farm and wild animals.

"Our chips have already been used very successfully in a survey of microbial resistance in human clinical isolates, foods, farm animals and also in wild animals, where we were looking at them as possible reservoirs of infection which can transmit disease back into farm animals", says Dr Anjum.

The miniaturised microarray chips were developed by studying and identifying the dangerous genes from samples of gut bacteria including the diarrhoea-causing E. coli bacteria and the food poisoning bug Salmonella.

In a test of the new chip screening technique, the most common antibiotic resistance gene was identified in 90% of E. coli and 56% of Salmonella bacteria from a random group of animal and human clinical samples. The tests even identified some unique and previously unknown combinations of virulence genes, whose significance still needs to be determined.

"In the near future, we are planning to automate the method to enable each sample to be tested for up to 600 genes and for 96 samples to be processed in half a day", says Dr Muna Anjum. "This will allow large scale monitoring of bacterial pathogens to see how they gain and lose genes related to disease and its control".

This technology will also allow scientists to search for and identify important genes from other pathogens and bacteria, for instance genes which may be commercially important in industrial processes such as waste handling, plastics production, manufacturing, food processing or pharmaceutical development.


'/>"/>
Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

Related biology technology :

1. Mastercycler Gradient Quick Programming Guide
2. QIAquick PCR Purification Kit
3. QuickLane 24 - 48 Hour Sequencing
4. QuickLyse Miniprep Kit
5. Quick peeks, Clawback Agreements, and the rules of electronic discovery
6. EraGen diagnostic passes UW tests, could quickly detect bird flu
7. Quick response manufacturing and biotech
8. Fiserv Credit Processing Selects System To Keep Transactions Quick
9. High sensitivity quantitation of metabolites of nitrofuran antibiotics in animal tissue using LC/MS/MS
10. WARF Granted New Antibiotics Patent
11. Oshkosh Truck spends $4.8 million on disaster-resistant network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
Breaking Biology Technology:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):